Days Inventory is also known as Days Sales of Inventory (DSI). VBI Vaccines's Average Total Inventories for the
three
months ended in Dec. 2023 was $8.02 Mil. VBI Vaccines's Cost of Goods Sold for the
three
months ended in Dec. 2023 was $2.94 Mil.
Hence, VBI Vaccines's Days Inventory for the
three
months ended in Dec. 2023 was 248.65.
The historical rank and industry rank for VBI Vaccines's Days Inventory or its related term are showing as below:
VBIV'
s Days Inventory Range Over the Past 10 Years
Min: 45.86 Med: 74.45 Max: 220.31
Current: 211.63
During the past 13 years, VBI Vaccines's highest Days Inventory was 220.31. The lowest was 45.86. And the median was 74.45.
VBIV's Days Inventory is ranked worse than 54.15% of 650
companies
in the Biotechnology industry
Industry Median: 190.305
vs VBIV: 211.63
VBI Vaccines's Days Inventory
increased
from Dec. 2022 (169.93) to Dec. 2023 (248.65).
It might indicate that VBI Vaccines's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
VBI Vaccines's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.37.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
VBI Vaccines's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 9.40.
VBI Vaccines Days Inventory Historical Data
The historical data trend for VBI Vaccines's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of VBI Vaccines's Days Inventory
For the Biotechnology subindustry, VBI Vaccines's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VBI Vaccines's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, VBI Vaccines's Days Inventory distribution charts can be found below:
* The bar in red indicates where VBI Vaccines's Days Inventory falls into.
VBI Vaccines Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
VBI Vaccines's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VBI Vaccines (NAS:VBIV) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
VBI Vaccines's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
VBI Vaccines's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
VBI Vaccines Days Inventory Related Terms
Thank you for viewing the detailed overview of VBI Vaccines's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VBIV has been successfully added to your 